Results 71 to 80 of about 1,246 (182)
Fibrinogen petoskey: Identification of a new dysfibrinogenemia characterized by altered release of fibrinopeptide A [PDF]
A new congenital dysfibrinogenemia, designated fibrinogen Petoskey, which was traced through four generations of a Michigan family, was found to exhibit an abnormally slow rate of release of fibrino-peptide A upon treatment with thrombin and batroxobin ...
Penner, John A. +2 more
core +1 more source
Management of inherited dysfibrinogenemia during pregnancy: a description of four consecutive cases.
Normal fibrinogen concentration and function are critical for the successful outcome of a pregnancy. In fact, fibrinogen abnormalities have been implicated in many adverse pregnancy outcomes including post-partum haemorrhage or thrombosis ...
PIZZOLO, Giovanni +7 more
core +1 more source
Modeling Human Dysfibrinogenemia in Zebrafish
The fibrinogen molecule plays a crucial role in blood coagulation. It is composed of 3 distinct chains named Aα, Bβ, and γ, coded respectively by FGA, FGB, and FGG genes.
Richard, Maxime Paul
core +1 more source
Acquired hypofibrinogenemia: current perspectives
Martin W Besser,1 Stephen G MacDonald2 1Department of Haematology, 2Department of Specialist Haemostasis, The Pathology Partnership, Addenbrooke’s Hospital, Cambridge, UK Abstract: Acquired hypofibrinogenemia is most frequently caused by ...
Besser MW, MacDonald SG
doaj
Healed retinal vasculitis in a child with hypofibrinogenemia
Dysfibrinogenemia is a hematological disorder resulting from a decreased or abnormal level of fibrinogen. We describe a child previously diagnosed with a case of hypofibrinogenemia, whose fundus evaluation revealed evidence of old retinal vasculitis.
Marushka Aguiar +2 more
doaj +1 more source
ABSTRACT Background To date, no studies have reported the evaluation of hemostatic activity in canine leukoreduced cryoprecipitate (LR‐CRYO) and leukoreduced cryopoor plasma (LR‐CPP). Objectives We aimed to compare the hemostatic activity of LR‐CRYO and LR‐CPP to leukoreduced fresh plasma (LR‐FP) and to evaluate the preservation of LR‐CRYO by ...
Roberta Perego +7 more
wiley +1 more source
Background: Congenital dysfibrinogenemia is characterized by reduced functional fibrinogen despite normal antigen levels. In some variants, assay specific effects may lead to diagnostic misclassification and inappropriate clinical management.
Emad Muhammad +10 more
doaj +1 more source
ABSTRACT To investigate the prevalence, clinical manifestations, and risk factors of hypofibrinogenemia after tigecycline use, which can disrupt coagulation and potentially hinder antimicrobial therapy. This observational study was conducted from January to December 2021 at a tertiary general hospital in China.
Xiaohui Liu +5 more
wiley +1 more source
Natural history of patients with congenital dysfibrinogenemia
We conducted a multicentre study of 101 subjects with Congenital Dysfibrinogenemia (CD) to characterize the incidence of hemorrhagic and thrombotic events as well as complications of pregnancy and surgery.
Lebreton, Aurelien +9 more
core +1 more source

